| abstract |
A pharmaceutical composition comprising (1S, 4R) -cis-4- [2-amino-6-cyclopropylamino) -9H.purin-9-yl] -2-cyclopenten-1-methanol, or a pharmaceutically acceptable derivative thereof, and a sweetening agent compatible with said (1S, 4R) -cis-4- [2-amino-6-cyclopropylamino) -9H.purin-9-yl] -2-cyclopenten-1-methanol. A process for formulating a pharmaceutical composition of (1S, 4R) -cis-4- [2-amino-6-cyclopropylamino) -9H.purin-9-yl] -2-cyclopenten-1-methanol for oral administration is also described. characterized in that it comprises the steps of associating (1S, 4R) -cis-4- [2-amino-6-cyclopropylamino) -9H.purin-9-yl] -2-cyclopenten-1-methanol, or a pharmaceutically acceptable derivative of same, with a sweetening agent that does not contain a carboxyl group. |